{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&questionFirstAnswered.=2017-07-24T12%3A54%3A02.843Z&humanIndexable=true", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2017-07-04&questionFirstAnswered.=2017-07-24T12%3A54%3A02.843Z&humanIndexable=true", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&questionFirstAnswered.=2017-07-24T12%3A54%3A02.843Z&humanIndexable=true&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&_page=0&questionFirstAnswered.=2017-07-24T12%3A54%3A02.843Z&humanIndexable=true", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&questionFirstAnswered.=2017-07-24T12%3A54%3A02.843Z&humanIndexable=true", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&questionFirstAnswered.=2017-07-24T12%3A54%3A02.843Z&humanIndexable=true", "items" : [{"_about" : "http://data.parliament.uk/resources/748357", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/748357/answer", "answerText" : {"_value" : "<p>The UK imports a wide variety of radioactive isotopes for medical use. These include radioisotopes used for medical imaging of cancers and for cancer therapy. As medical radio-isotopes are not special fissile material, they are not subject to international safeguards and their availability in the UK should not be impacted by withdrawal from Euratom.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4068", "label" : {"_value" : "Biography information for Lord Harrington of Watford"}
        }
        , "answeringMemberConstituency" : {"_value" : "Watford"}
        , "answeringMemberPrinted" : {"_value" : "Richard Harrington"}
        , "dateOfAnswer" : {"_value" : "2017-07-24", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/748357/answer/previousversion/3149", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4068", "label" : {"_value" : "Biography information for Lord Harrington of Watford"}
          }
          , "answeringMemberConstituency" : {"_value" : "Watford"}
          , "answeringMemberPrinted" : {"_value" : "Richard Harrington"}
        }
        , "questionFirstAnswered" : [{"_value" : "2017-07-24T12:54:02.843Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Euratom"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the effect of the UK withdrawing from Euratom on cancer research in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "2969"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}